Z Squared Inc.
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical and technology company operating through subsidiaries that are majority or wholly owned. Its biopharmaceutical business develops cell therapy platforms and related diagnostic technologies for cancer, autoimmune and infectious diseases. Programs include GEAR,… From the company’s description.
Over the twelve months to Jun 30, 2026, Z Squared Inc. reported revenue of $2.68M, up 915.9% from a year earlier, and a net loss of $18.32M. In fiscal 2025, it reported revenue of $1.36M and a net loss of $12.28M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Z Squared Inc. does
In the company’s own words
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical and technology company operating through subsidiaries that are majority or wholly owned. Its biopharmaceutical business develops cell therapy platforms and related diagnostic technologies for cancer, autoimmune and infectious diseases. Programs include GEAR, which is designed to modify immune cells for use with antibody therapies; the SNAP-CAR platform, which pairs engineered immune cells with antibody adaptors to target cancer; and unmodified natural killer cell therapies for blood cancers and viral infections. The company also holds rights to CD38-Diagnostic, a tool intended to assess patient suitability for anti-CD38 therapies. Its technology business offers managed digital marketing services, including lead generation, content and social media marketing, email campaigns, analytics and branding, supported by AI-powered software and robotic process automation. Coeptis acquired the NexGenAI platform assets in 2024. The company reports six employees as of the filing, including four full-time and two part-time employees. Its website is https://coeptistx.com.
Company details
- Sector
- Financials
- Industry (SIC)
- Finance Services
- Headquarters
- FORT LAUDERDALE, FL
- Fiscal year end
- December
- CIK
- 1759186
- SIC
- 6199
Financial performance, year by year
Fiscal 2020–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Z Squared Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Z Squared Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Z Squared Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Z Squared Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Z Squared Inc.'s last four quarterly filings that the numbers alone won't show?”